Clinical Trials Directory

Trials / Terminated

TerminatedNCT04386278

OrthoPulse Gen 2 Initial Device Evaluation and Assessment of Clinical Effectiveness (CA)

RI.2 OrthoPulse Gen 2 Initial Device Evaluation and Assessment of Clinical

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Biolux Research Holdings, Inc. · Industry
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

This is a prospective, interventional, non-randomized, control, split-mouth, open-label, single centre, private practice study aimed to evaluate the effect of tooth movement during orthodontic treatment using a removeable thermoplastic orthodontic appliance. Intrusion and extrusion will be conducted using bilaterally equivalent elastomeric forces of 50 grams. A comparison of the rate of bilateral orthodontic tooth movement will be conducted using six (6) varied photobiomodulation interventions on the maxillary (upper) and mandibular (lower) arches. The OrthoPulse Gen 2 and OrthoPulse (commercially approved) devices are being used in this clinical investigation. Each subject enrolled will go through intrusion and extrusion. All subjects will be allocated to an OrthoPulse split-mouth intervention by the investigator.

Conditions

Interventions

TypeNameDescription
DEVICEIntervention 1Side one: No treatment Side two: OrthoPulse Gen 2 (2RP) for one minute
DEVICEIntervention 2Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RP) for one minute
DEVICEIntervention 3Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RP) for 5 minutes
DEVICEIntervention 4Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RCW) for five minutes
DEVICEIntervention 5Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for one minute
DEVICEIntervention 6Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for five minutes
DEVICEIntervention 7Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for one minute
DEVICEIntervention 8Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RBP) for five minutes

Timeline

Start date
2020-01-08
Primary completion
2020-06-24
Completion
2020-06-24
First posted
2020-05-13
Last updated
2020-11-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04386278. Inclusion in this directory is not an endorsement.